Sava Infond D.O.O. Boston Scientific Corp Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Boston Scientific Corp stock. As of the latest transaction made, Sava Infond D.O.O. holds 53,870 shares of BSX stock, worth $5.31 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
53,870
Previous 47,310
13.87%
Holding current value
$5.31 Million
Previous $4.77 Billion
21.24%
% of portfolio
0.9%
Previous 0.91%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,936Shares Held
1.27BCall Options Held
9.59MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.5 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.43 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.42 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.34 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $141B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...